Arthur Becker

CEO at OncoPep

As well as leading OncoPep, Becker serves as the Chair of the Board of VisgenX, a start-up focused on a novel approach to "Dry" Age Related Macular Degeneration (Dry AMD). He is a Venture Partner with CoBro Ventures and is on the Boards of NextRNA, Al Proteins, and OncoPep. He is also a Managing Member of Madison Technology, LLC, an investment firm focused on early-stage Fin lech ventures.

Becker was formerly the Chairman & CEO of Zinio, LLC, (2012-2015) the world's largest digital newsstand. Prior to joining Zinio, Mr. Becker was the CEO of NaviSite, a NASDAQ quoted company that provided internet technology services, hosting, and colocation to businesses in the US and UK from 2002-2010. With offices in the US, UK, and India, NaviSite provided data center hosting and cloud-based application management for the enterprise market. Arthur was a senior advisor to the Vera Wang fashion company for 7 years and has been a private investor in technology and real estate since NaviSite was sold to lime Warner in 2011.

Location

New York, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


OncoPep

Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.


Industries

Employees

11-50

Links